The advent of cell and gene therapies heralds a powerful shift, but without deliberate attention to financing, delivery, data ...

The concept rests on assumptions that are unsupported by evidence. Consequently, current proposals for mandatory ...

As HHS Secretary, Robert F. Kennedy Jr. has selectively cherry-picked many of his long-standing interests and their purported ...

Despite a lack of evidence of clinical benefit and substantial safety and quality concerns, an FDA advisory committee ...

Since 1971, protection against measles, mumps, and rubella has been delivered in a single combined injection. A proposal to ...

Many details of these agreements remain undisclosed, but what we know suggests they may be less far-reaching than claimed.

The rapid growth of private equity (PE) and publicly traded corporation (PTC) ownership in hospice has raised concerns that investor-driven profit incentives may undermine care quality. Evidence on ...

Pediatrics is increasingly moving toward regionalized hub-and-spoke models organized around comprehensive “centers of ...

The current MA risk adjustment model has shortcomings, both in predictive accuracy and payment equity across the Medicare ...

Understanding the impact of price controls on drug research and approvals of secondary indications is critical for policy ...

What California chooses in the next six months will determine whether a decade of Medicaid transformation holds or collapses ...

Medicare Advantage (MA) has become a major source of dental coverage for older US adults. However, little is known about enrollment in plans with dental coverage or about the scope and continued ...